Results 181 to 190 of about 22,410 (257)

Waveguide‐Based Retinal Projection Near‐Eye Display with Bidirectional Eyebox Expansion

open access: yesAdvanced Intelligent Systems, EarlyView.
A waveguide‐type retinal projection display system with bidirectional extended eyebox is proposed. The two‐layer holographic optical elements (HOEs), with two eye reliefs of 11 and 12 mm in the axial direction, serve as the image combiner, and each layer of HOEs generates two viewpoints with a horizontal spacing of 5 mm. Based on the mechanism of human
Yujing Fu   +4 more
wiley   +1 more source

Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: An immunocytochemical study

open access: bronze, 1996
Theo Thepen   +6 more
openalex   +1 more source

Reciprocal Regulation of Th1- and Th2-Cytokine-Producing T Cells during Clearance of Parasitemia inPlasmodium falciparumMalaria [PDF]

open access: bronze, 1998
Stefan Winkler   +6 more
openalex   +1 more source

Biodiversity of the Bacterial and Fungal Microbiome and Associated Inflammatory Cytokine Profile in Chronic Rhinosinusitis

open access: yesInternational Forum of Allergy &Rhinology, Volume 15, Issue 5, Page 502-512, May 2025.
ABSTRACT Background Dysbiosis of the bacterial and fungal microbiome has been increasingly implicated in the pathogenesis of chronic rhinosinusitis (CRS). This study explores the relationship between microbiome and mycobiome biodiversity and type 2 (T2) versus non‐type 2 (NT2) inflammation.
Hong‐Ho Yang   +13 more
wiley   +1 more source

Persistent Eosinophilic Inflammation Is Not a Feature of Type 2 CRS Patients Failing Anti‐IL‐5R Therapy and Requiring Class Switching to Anti‐IL‐4/13

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Type 2 inflammation dominates eosinophilic chronic rhinosinusitis (eCRS) and adult onset asthma. IL‐4, ‐5, and ‐13 are prominent disease mediators. Disease control can be achieved with biologic therapies. However, despite some patients entering remission, others experience poor control. Aim We aimed to describe eCRS patients treated
Peta‐Lee Sacks   +8 more
wiley   +1 more source

CD28 costimulation promotes the production of Th2 cytokines.

open access: bronze, 1997
Ingrid C. Rulifson   +4 more
openalex   +1 more source

MiR‐221‐3p Attenuates IL‐33‐Induced Mast Cell Cytokine Expression by Targeting KIT

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Mast cells (MCs) are involved in type 2 inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP), which depends on interleukin (IL)‐33 stimulation. MiR‐221 is reported to be an important regulator of MCs, and miR‐221‐3p can be expressed in CRSwNP. However, the role of miR‐221‐3p in CRSwNP is unclear. Methods Ethmoid tissues
Ruowu Liu   +11 more
wiley   +1 more source

Near‐Zero Thermal Expansion in Coordination Polymer Cd(1,2,4‐Triazole)2(H2PO4)2

open access: yesAngewandte Chemie, EarlyView.
The structural dynamics and the chemical bonding origin of a volumetric near‐zero thermal expansion in a coordination polymer across 25 K to 400 K is studied using multi‐temperature X‐ray crystallography and X‐ray electron density analysis. The lattice expansion in the a and c directions is counteracted by contraction along b axis, caused by concerted ...
Sounak Sarkar, Bo Brummerstedt Iversen
wiley   +2 more sources

Deficiency of DEK proto‐oncogene alleviates allergic rhinitis by inhibiting RhoA/Ezrin‐mediated mitochondrial fission

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Schematic diagram of the mechanism of DEK regulating RhoA activation Ezrin. Upon house dust mite (HDM) stimulation, HDM‐specific immunoglobulin E (IgE) and inflammatory factors such as interleukin 4 (IL‐4), IL‐5, IL‐13, and eosinophils increased in the nasal mucosa.
Longzhu Dai   +8 more
wiley   +1 more source

Infectious Th1 and Th2 autoimmunity in diabetes‐prone mice [PDF]

open access: bronze, 1998
Jide Tian   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy